Cognitive deficits in Parkinson’s disease with excessive daytime sleepiness: a systematic review

References

• Aarsland, D., Andersen, K., Larsen, J. P., & Lolk, A. (2003). Prevalence and characteristics of dementia in Parkinson disease: An 8-year prospective study. Archives of Neurology, 60(3), 387–392.
   PubMedGoogle Scholar
• Aarsland, D., Brønnick, K., Larsen, J., Tysnes, O., & Alves, G. (2009). Cognitive impairment in incident, untreated Parkinson disease: The Norwegian ParkWest study. Neurology, 72(13), 1121–1126.
   PubMed Web of Science ®Google Scholar
• Aarsland, D., Bronnick, K., Williams-Gray, C., Weintraub, D., Marder, K., Kulisevsky, J., … Emre, M. (2010). Mild cognitive impairment in Parkinson disease: A multicenter pooled analysis. Neurology, 75(12), 1062–1069.
   PubMed Web of Science ®Google Scholar
• Aarsland, D., Zaccai, J., & Brayne, C. (2005). A systematic review of prevalence studies of dementia in Parkinson's disease. Movement Disorders, 20(10), 1255–1263.
   PubMed Web of Science ®Google Scholar
• Abbott, R. D., Ross, G. W., White, L. R., Tanner, C. M., Masaki, K. H., Nelson, J. S., … Petrovitch, H. (2005). Excessive daytime sleepiness and subsequent development of Parkinson disease. Neurology, 65(9), 1442–1446.
   PubMed Web of Science ®Google Scholar
• Adler, C. H., Caviness, J. N., Hentz, J. G., Lind, M., & Tiede, J. (2003). Randomized trial of modafinil for treating subjective daytime sleepiness in patients with Parkinson's disease. Movement Disorders, 18(3), 287–293.
   PubMed Web of Science ®Google Scholar
• Amara, A. W., Chahine, L. M., Caspell-Garcia, C., Long, J. D., Coffey, C., Högl, B., … Simuni, T. (2017). Longitudinal assessment of excessive daytime sleepiness in early Parkinson’s disease. Journal of Neurology, Neurosurgery & Psychiatry, 88(8), 653–662.
   PubMed Web of Science ®Google Scholar
• Arnulf, I., Konofal, E., Merino-Andreu, M., Houeto, J. L., Mesnage, V., Welter, M. L., … Agid, Y. (2002). Parkinson's disease and sleepiness: An integral part of PD. Neurology, 58(7), 1019–1024.
   PubMed Web of Science ®Google Scholar
• Bell‐McGinty, S., Podell, K., Franzen, M., Baird, A. D., & Williams, M. J. (2002). Standard measures of executive function in predicting instrumental activities of daily living in older adults. International Journal of Geriatric Psychiatry, 17(9), 828–834.
   PubMed Web of Science ®Google Scholar
• Bixler, E., Vgontzas, A., Lin, H.-M., Calhoun, S., Vela-Bueno, A., & Kales, A. (2005). Excessive daytime sleepiness in a general population sample: The role of sleep apnea, age, obesity, diabetes, and depression. The Journal of Clinical Endocrinology & Metabolism, 90(8), 4510–4515.
   PubMed Web of Science ®Google Scholar
• Bjørnarå, K. A., Dietrichs, E., & Toft, M. (2014). Clinical features associated with sleep disturbances in Parkinson’s disease. Clinical Neurology and Neurosurgery, 124, 37–43.
   PubMed Web of Science ®Google Scholar
• Bolitho, S. J., Naismith, S. L., Salahuddin, P., Terpening, Z., Grunstein, R. R., & Lewis, S. J. (2013). Objective measurement of daytime napping, cognitive dysfunction and subjective sleepiness in Parkinson’s disease. PLoS One, 8(11), e81233.
   PubMed Web of Science ®Google Scholar
• Bonanni, E., Maestri, M., Tognoni, G., Fabbrini, M., Nucciarone, B., Manca, M. L., … Murri, L. (2005). Daytime sleepiness in mild and moderate Alzheimer's disease and its relationship with cognitive impairment. Journal of Sleep Research, 14(3), 311–317.
   PubMed Web of Science ®Google Scholar
• Chou, K. L., Amick, M. M., Brandt, J., Camicioli, R., Frei, K., Gitelman, D., … Uc, E. Y. (2010). A recommended scale for cognitive screening in clinical trials of Parkinson's disease. Movement Disorders, 25(15), 2501–2507.
   PubMed Web of Science ®Google Scholar
• Cools, R. (2006). Dopaminergic modulation of cognitive function-implications for L-DOPA treatment in Parkinson's disease. Neuroscience & Biobehavioral Reviews, 30(1), 1–23.
   PubMed Web of Science ®Google Scholar
• Cools, R., Barker, R. A., Sahakian, B. J., & Robbins, T. W. (2001). Enhanced or impaired cognitive function in Parkinson's disease as a function of dopaminergic medication and task demands. Cerebral Cortex, 11(12), 1136–1143.
   PubMed Web of Science ®Google Scholar
• Elbaz, A., Carcaillon, L., Kab, S., & Moisan, F. (2016). Epidemiology of Parkinson's disease. Revue Neurologique, 172(1), 14–26.
   PubMed Web of Science ®Google Scholar
• Fénelon, G., Mahieux, F., Huon, R., & Ziégler, M. (2000). Hallucinations in Parkinson's disease: Prevalence, phenomenology and risk factors. Brain, 123(4), 733–745.
   PubMed Web of Science ®Google Scholar
• Floyd, J. A., Medler, S. M., Ager, J. W., & Janisse, J. J. (2000). Age‐related changes in initiation and maintenance of sleep: A meta‐analysis. Research in Nursing & Health, 23(2), 106–117.
   PubMed Web of Science ®Google Scholar
• Foley, D. J., Vitiello, M. V., Bliwise, D. L., Ancoli-Israel, S., Monjan, A. A., & Walsh, J. K. (2007). Frequent napping is associated with excessive daytime sleepiness, depression, pain, and nocturia in older adults: Findings from the National Sleep Foundation ‘2003 Sleep in America’ Poll. The American Journal of Geriatric Psychiatry, 15(4), 344–350.
   PubMed Web of Science ®Google Scholar
• Ghorayeb, I., Loundou, A., Auquier, P., Dauvilliers, Y., Bioulac, B., & Tison, F. (2007). A nationwide survey of excessive daytime sleepiness in Parkinson's disease in France. Movement Disorders, 22(11), 1567–1572.
   PubMed Web of Science ®Google Scholar
• Gjerstad, M., Alves, G., Wentzel-Larsen, T., Aarsland, D., & Larsen, J. (2006). Excessive daytime sleepiness in Parkinson disease: Is it the drugs or the disease? Neurology, 67(5), 853–858.
   PubMed Web of Science ®Google Scholar
• Goldman, J. G., Ghode, R. A., Ouyang, B., Bernard, B., Goetz, C. G., & Stebbins, G. T. (2013). Dissociations among daytime sleepiness, nighttime sleep, and cognitive status in Parkinson's disease. Parkinsonism & Related Disorders, 19(9), 806–811.
   PubMed Web of Science ®Google Scholar
• Gooneratne, N. S., Weaver, T. E., Cater, J. R., Pack, F. M., Arner, H. M., Greenberg, A. S., & Pack, A. I. (2003). Functional outcomes of excessive daytime sleepiness in older adults. Journal of the American Geriatrics Society, 51(5), 642–649.
   PubMed Web of Science ®Google Scholar
• Hays, J. C., Blazer, D. G., & Foley, D. J. (1996). Risk of napping: Excessive daytime sleepiness and mortality in an older community population. Journal of the American Geriatrics Society, 44(6), 693–698.
   PubMed Web of Science ®Google Scholar
• Hely, M. A., Reid, W. G., Adena, M. A., Halliday, G. M., & Morris, J. G. (2008). The Sydney multicenter study of Parkinson's disease: The inevitability of dementia at 20 years. Movement Disorders, 23(6), 837–844.
   PubMed Web of Science ®Google Scholar
• Henry, J. D., & Crawford, J. R. (2004). Verbal fluency deficits in Parkinson's disease: A meta-analysis. Journal of the International Neuropsychological Society, 10(4), 608–622.
   PubMed Web of Science ®Google Scholar
• Hilten, J. J., Weggeman, M., Velde, E. A., Kerkhof, G. A., Dijk, J. G., & Roos, R. A. C. (1993). Sleep, excessive daytime sleepiness and fatigue in Parkinson's disease. Journal of Neural Transmission – Parkinson's Disease and Dementia Section, 5(3), 235–244.
   Google Scholar
• Hobson, D. E., Lang, A. E., Martin, W. W., Razmy, A., Rivest, J., & Fleming, J. (2002). Excessive daytime sleepiness and sudden-onset sleep in Parkinson disease: A survey by the Canadian Movement Disorders Group. JAMA, 287(4), 455–463.
   PubMed Web of Science ®Google Scholar
• Hoch, C. C., Dew, M. A., Reynolds, C. F., Monk, T. H., Buysse, D. J., Houck, P. R., … Kupfer, D. J. (1994). A longitudinal study of laboratory-and diary-based sleep measures in healthy “old old” and “young old” volunteers. Sleep, 17(6), 489–496.
   PubMed Web of Science ®Google Scholar
• Hoehn, M. M., & Yahr, M. D. (1998). Parkinsonism: Onset, progression, and mortality. Neurology, 50(2), 318–318.
   PubMed Web of Science ®Google Scholar
• Högl, B., Saletu, M., Brandauer, E., Glatzl, S., Frauscher, B., Seppi, K., … Poewe, W. (2002). Modafinil for the treatment of daytime sleepiness in Parkinson´ s disease: A double-blind, randomized, crossover, placebo-controlled polygraphic trial. Sleep. 25(8), 62–66.
   Web of Science ®Google Scholar
• Hoops, S., Nazem, S., Siderowf, A., Duda, J., Xie, S., Stern, M., & Weintraub, D. (2009). Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease. Neurology, 73(21), 1738–1745.
   PubMed Web of Science ®Google Scholar
• Hornykiewicz, O. (1974). The mechanisms of action of L-DOPA in Parkinson's disease. Life Sciences, 15(7), 1249–1260.
   Google Scholar
• Jaussent, I., Bouyer, J., Ancelin, M.-L., Berr, C., Foubert-Samier, A., Ritchie, K., … Dauvilliers, Y. (2012). Excessive sleepiness is predictive of cognitive decline in the elderly. Sleep, 35(9), 1201–1207.
   PubMed Web of Science ®Google Scholar
• Johnson, J. K., Lui, L.-Y., & Yaffe, K. (2007). Executive function, more than global cognition, predicts functional decline and mortality in elderly women. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 62(10), 1134–1141.
   PubMed Web of Science ®Google Scholar
• Kudlicka, A., Clare, L., & Hindle, J. V. (2011). Executive functions in Parkinson's disease: Systematic review and meta‐analysis. Movement Disorders, 26(13), 2305–2315.
   PubMed Web of Science ®Google Scholar
• Kulisevsky, J. (2000). Role of dopamine in learning and memory: Implications for the treatment of cognitive dysfunction in patients with Parkinson's disease. Drugs & Aging, 16(5), 365–379.
   PubMed Web of Science ®Google Scholar
• Kulisevsky, J., Avila, A., Barbanoj, M., Antonijoan, R., Berthier, M. L., & Gironell, A. (1996). Acute effects of levodopa on neuropsychological performance in stable and fluctuating Parkinson's disease patients at different levodopa plasma levels. Brain, 119(6), 2121–2132.
   PubMedGoogle Scholar
• Kummer, A., Scalzo, P., Cardoso, F., & Teixeira, A. L. (2011). Evaluation of fatigue in Parkinson’s disease using the Brazilian version of Parkinson’s Fatigue Scale. Acta Neurologica Scandinavica, 123(2), 130–136.
   PubMed Web of Science ®Google Scholar
• Lee, S., Almeida, D. M., Berkman, L., Olson, R., Moen, P., & Buxton, O. M. (2016). Age differences in workplace intervention effects on employees' nighttime and daytime sleep. Sleep Health, 2(4), 289–296.
   PubMed Web of Science ®Google Scholar
• Leroi, I., Baker, P., Kehoe, P., Daniel, E., & Byrne, E. J. (2010). A pilot randomized controlled trial of sleep therapy in Parkinson's disease: Effect on patients and caregivers. International Journal of Geriatric Psychiatry, 25(10), 1073–1079.
   PubMed Web of Science ®Google Scholar
• Lou, J.-S., Dimitrova, D. M., Park, B. S., Johnson, S. C., Eaton, R., Arnold, G., & Nutt, J. G. (2009). Using modafinil to treat fatigue in Parkinson disease: A double-blind, placebo-controlled pilot study. Clinical Neuropharmacology, 32(6), 305–310.
   PubMed Web of Science ®Google Scholar
• Marinus, J., & van Hilten, J. J. (2015). The significance of motor (A) symmetry in Parkinson's disease. Movement Disorders, 30(3), 379–385.
   PubMed Web of Science ®Google Scholar
• Muslimović, D., Post, B., Speelman, J. D., & Schmand, B. (2005). Cognitive profile of patients with newly diagnosed Parkinson disease. Neurology, 65(8), 1239–1245.
   PubMed Web of Science ®Google Scholar
• Muslimović, D., Schmand, B., Speelman, J. D., & De Haan, R. J. (2007). Course of cognitive decline in Parkinson's disease: A meta-analysis. Journal of the International Neuropsychological Society, 13(6), 920–932.
   PubMed Web of Science ®Google Scholar
• Naismith, S. L., Terpening, Z., Shine, J. M., & Lewis, S. J. (2011). Neuropsychological functioning in Parkinson's disease: Differential relationships with self‐reported sleep–wake disturbances. Movement Disorders, 26(8), 1537–1541.
   PubMed Web of Science ®Google Scholar
• O'Suilleabhain, P. E., & Dewey, R. B. Jr, (2002). Contributions of dopaminergic drugs and disease severity to daytime sleepiness in Parkinson disease. Archives of Neurology, 59(6), 986–989.
   PubMedGoogle Scholar
• Ohayon, M. M., Carskadon, M. A., Guilleminault, C., & Vitiello, M. V. (2004). Meta-analysis of quantitative sleep parameters from childhood to old age in healthy individuals: Developing normative sleep values across the human lifespan. Sleep, 27(7), 1255–1273.
   PubMed Web of Science ®Google Scholar
• Ohayon, M. M., & Zulley, J. (1999). Prevalence of naps in the general population. Sleep and Hypnosis, 1(2), 88–97.
   Google Scholar
• Ondo, W., Fayle, R., Atassi, F., & Jankovic, J. (2005). Modafinil for daytime somnolence in Parkinson’s disease: Double blind, placebo controlled parallel trial. Journal of Neurology, Neurosurgery & Psychiatry, 76(12), 1636–1639.
   PubMed Web of Science ®Google Scholar
• Paus, S., Brecht, H. M., Köster, J., Seeger, G., Klockgether, T., & Wüllner, U. (2003). Sleep attacks, daytime sleepiness, and dopamine agonists in Parkinson's disease. Movement Disorders, 18(6), 659–667.
   PubMed Web of Science ®Google Scholar
• Paus, S., Schmitz‐Hübsch, T., Wüllner, U., Vogel, A., Klockgether, T., & Abele, M. (2007). Bright light therapy in Parkinson's disease: A pilot study. Movement Disorders, 22(10), 1495–1498.
   PubMed Web of Science ®Google Scholar
• Pushpanathan, M. E., Loftus, A. M., Thomas, M. G., Gasson, N., & Bucks, R. S. (2016). The relationship between sleep and cognition in Parkinson's disease: A meta-analysis. Sleep Medicine Reviews, 26, 21–32.
   PubMed Web of Science ®Google Scholar
• Razmy, A., Lang, A. E., & Shapiro, C. M. (2004). Predictors of impaired daytime sleep and wakefulness in patients with Parkinson disease treated with older (ergot) vs newer (nonergot) dopamine agonists. Archives of Neurology, 61(1), 97–102.
   PubMedGoogle Scholar
• Rodrigues, T. M., Caldas, A. C., & Ferreira, J. J. (2016). Pharmacological interventions for daytime sleepiness and sleep disorders in Parkinson's disease: Systematic review and meta-analysis. Parkinsonism & Related Disorders, 27, 25–34.
   PubMed Web of Science ®Google Scholar
• Royall, D. R., Palmer, R., Chiodo, L. K., & Polk, M. J. (2004). Declining executive control in normal aging predicts change in functional status: The Freedom House Study. Journal of the American Geriatrics Society, 52(3), 346–352.
   PubMed Web of Science ®Google Scholar
• Schrag, A., Jahanshahi, M., & Quinn, N. (2000). What contributes to quality of life in patients with Parkinson's disease? Journal of Neurology, Neurosurgery & Psychiatry, 69(3), 308–312.
   PubMed Web of Science ®Google Scholar
• Sheng, P., Hou, L., Wang, X., Wang, X., Huang, C., Yu, M., … Dong, Y. (2013). Efficacy of modafinil on fatigue and excessive daytime sleepiness associated with neurological disorders: A systematic review and meta-analysis. PloS One, 8(12), e81802.
   PubMed Web of Science ®Google Scholar
• Simuni, T., Caspell-Garcia, C., Coffey, C., Chahine, L. M., Lasch, S., Oertel, W. H., … Marek, K. (2015). Correlates of excessive daytime sleepiness in de novo Parkinson's disease: A case control study. Movement Disorders, 30(10), 1371–1381.
   PubMed Web of Science ®Google Scholar
• Tandberg, E., Larsen, J. P., & Karlsen, K. (1999). Excessive daytime sleepiness and sleep benefit in Parkinson's disease: A community‐based study. Movement Disorders, 14(6), 922–927.
   PubMed Web of Science ®Google Scholar
• Ueno, T., Kon, T., Haga, R., Nishijima, H., & Tomiyama, M. (2018). Motor vehicle accidents in Parkinson's disease: A questionnaire study. Acta Neurologica Scandinavica, 137(2), 218–223.
   PubMed Web of Science ®Google Scholar
• Videnovic, A., Noble, C., Reid, K. J., Peng, J., Turek, F. W., Marconi, A., … Zee, P. C. (2014). Circadian melatonin rhythm and excessive daytime sleepiness in Parkinson disease. JAMA Neurology, 71(4), 463–469.
   PubMed Web of Science ®Google Scholar
• Wang, G., Li, X.-J., Hu, Y.-S., Cheng, Q., Wang, C.-F., Xiao, Q., … Chen, S.-D. (2015). Mortality from Parkinson’s disease in China: Findings from a five-year follow up study in Shanghai. Canadian Journal of Neurological Sciences, 42(4), 242–247.
   PubMed Web of Science ®Google Scholar
• Weintraub, D., Moberg, P. J., Duda, J. E., Katz, I. R., & Stern, M. B. (2004). Effect of psychiatric and other nonmotor symptoms on disability in Parkinson's disease. Journal of the American Geriatrics Society, 52(5), 784–788.
   PubMed Web of Science ®Google Scholar
• Wen, M.-C., Ng, S. Y., Heng, H. S., Chao, Y. X., Chan, L. L., Tan, E. K., & Tan, L. C. (2016). Neural substrates of excessive daytime sleepiness in early drug naïve Parkinson's disease: A resting state functional MRI study. Parkinsonism & Related Disorders, 24, 63–68.
   PubMed Web of Science ®Google Scholar
• Yousaf, T., Pagano, G., Niccolini, F., & Politis, M. (2018). Excessive daytime sleepiness may be associated with caudate denervation in Parkinson disease. Journal of the Neurological Sciences, 387, 220–227.
   PubMed Web of Science ®Google Scholar
• Zhang, Y., Wang, C., Wang, Y., Xiao, Q., Liu, J., Ma, J., … Wang, G. (2018). Mortality from Parkinson's disease in China: Findings from a ten-year follow up study in Shanghai. Parkinsonism & Related Disorders, 55, 75–80.
   PubMed Web of Science ®Google Scholar
• Zhu, K., van Hilten, J., & Marinus, J. (2017). Onset and evolution of anxiety in Parkinson's disease. European Journal of Neurology, 24(2), 404–411.
   PubMed Web of Science ®Google Scholar
• Zhu, K., van Hilten, J. J., & Marinus, J. (2014). Predictors of dementia in Parkinson's disease; Findings from a 5-year prospective study using the SCOPA-COG. Parkinsonism & Related Disorders, 20(9), 980–985.
   PubMed Web of Science ®Google Scholar
• Zhu, K., van Hilten, J. J., & Marinus, J. (2016). Course and risk factors for excessive daytime sleepiness in Parkinson's disease. Parkinsonism & Related Disorders, 24, 34–40.
   PubMed Web of Science ®Google Scholar
• Zhu, K., van Hilten, J. J., Putter, H., & Marinus, J. (2013). Risk factors for hallucinations in Parkinson's disease: Results from a large prospective cohort study. Movement Disorders, 28(6), 755–762.
   PubMed Web of Science ®Google Scholar